The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Adult Vaccines Market By 2030 Starting From Its 2026 Size?
The adult vaccines market has demonstrated substantial growth in recent years. Looking ahead, it is projected to expand from $24.21 billion in 2025 to $26.34 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. This historical expansion can be attributed to several factors, including the increasing prevalence of infectious diseases, government immunization initiatives, the development of novel vaccines, a growing geriatric population, and expanding healthcare infrastructure.
The adult vaccines market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $37.51 billion, exhibiting a compound annual growth rate (CAGR) of 9.2%. This projected growth during the forecast period is fueled by several factors, including advancements in mRNA and recombinant vaccine technologies, a surge in investments for adult immunization initiatives, the broadening of cold chain logistics, heightened public awareness regarding vaccine-preventable illnesses, and increased partnerships between pharmaceutical and biotechnology firms. Key trends anticipated during this period encompass a heightened understanding of adult vaccination benefits, the extension of immunization programs, the creation of combination vaccines, an increase in vaccines designed for chronic disease management, and a growing need for vaccines related to travel and occupational health.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp
Which Market Drivers Are Supporting The Expansion Of The Adult Vaccines Market?
Rising spending on healthcare fostered the expansion of the adult vaccine market. This spending encompasses the overall cost for medical services delivered to a populace. Elevated healthcare spending frequently directs more resources towards medical research and development efforts. Through investment in immunization programs and enhanced vaccine availability, health systems can alleviate the weight of preventable illnesses and enhance general population well-being. Furthermore, adult immunization offers substantial financial benefits by decreasing the use of healthcare services and the requirement for costly therapies. For example, reports from the Canadian Institute for Health Information, a Canada-based health company, indicated in November 2023 that Canada’s overall health expenditure for 2023 is estimated to hit $344 billion, representing an increase exceeding $9 billion from 2022. Consequently, the surge in healthcare expenditure favorably influenced the expansion of the adult vaccine market.
Which Segment Categories Define The Adult Vaccines Market?
The adult vaccines market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals
Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines
What Major Market Trends Are Driving Changes In The Adult Vaccines Market?
Leading firms within the adult vaccines sector are prioritizing the development of advanced technologies, notably mRNA-based vaccines, to generate rapid and precise immune responses, thereby addressing the increasing need for adult immunization against respiratory illnesses. Such vaccines employ messenger RNA enclosed within lipid nanoparticles to direct human cells to synthesize particular viral proteins, stimulating an immune response without relying on live or attenuated viruses. As an illustration, in May 2024, Moderna, a US-based biotechnology company, obtained FDA approval for mRESVI, which is an mRNA respiratory syncytial virus (RSV) vaccine designed for adults 60 years and older. This vaccine encodes the prefusion F glycoprotein of RSV and comes in single-dose, pre-filled syringes, facilitating the production of neutralizing antibodies, enhancing safety and efficacy relative to conventional inactivated or live-attenuated vaccines, and broadening the available immunization choices for adults.
Who Are The Top Companies Competing In The Adult Vaccines Market?
Major companies operating in the adult vaccines market are GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited
Read the full adult vaccines market report here:
https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report
How Is The Adult Vaccines Market Distributed Across Key Geographic Regions?
North America was the largest region in the adult vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Adult Vaccines Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp
Browse Through More Reports Similar to the Global Adult Vaccines Market 2026, By The Business Research Company
Adult Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Pediatric Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model